Description
TIGIT (Tiragolumab Biosimilar) Human mAb was confirmed to bind to its intended target protein TIGIT using flow cytometry. TIGIT (Tiragolumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Tiragolumab is an antibody directed against the extracellular region of human TIGIT.
Target
TIGIT
Target Alias Name
TIGIT
Isotype/Mimetic
IgG1 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation